Year: 2020

news_6

HiFiBiO Therapeutics Announces a Global Strategic Partnership With ABL Bio for the Co-Development of a SARS-CoV-2 Neutralizing Antibody

CAMBRIDGE, Mass. & PARIS & SHANGHAI & HONG KONG--(BUSINESS WIRE)--HiFiBiO Therapeutics, a clinical-stage multinational biotherapeutics company focused on the development...

news_6

First Patient Enrolled in AVITA Therapeutic’s Pivotal Study Evaluating the RECELL System for Repigmentation of Stable Vitiligo

VALENCIA, Calif. & MELBOURNE, Australia--(BUSINESS WIRE)--AVITA Therapeutics, Inc. (NASDAQ: RCEL, ASX:AVH), a regenerative medicine company that is developing and commercializing...

news_6

DKT WomanCare and Incepta Pharmaceuticals Ink Strategic Deal to Expand Markets, Scale Up Access to World-Class Injectable Contraceptive in 40 Countries

PARIS--(BUSINESS WIRE)--WomanCare Global Trading CIC (DKT WomanCare) and Incepta Pharmaceuticals, Ltd. signed a strategic agreement on July 1, 2020 to...